148 related articles for article (PubMed ID: 29226154)
1. Reduced Transferrin Levels in Active Inflammatory Bowel Disease.
Matusiewicz M; Neubauer K; Lewandowska P; Gamian A; Krzystek-Korpacka M
Biomed Res Int; 2017; 2017():9541370. PubMed ID: 29226154
[TBL] [Abstract][Full Text] [Related]
2. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2009 Jan; 15(1):93-9. PubMed ID: 18626964
[TBL] [Abstract][Full Text] [Related]
4. Enhanced formation of advanced oxidation protein products in IBD.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
[TBL] [Abstract][Full Text] [Related]
5. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
7. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of circulating midkine in ulcerative colitis.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Clin Chem Lab Med; 2009; 47(9):1085-90. PubMed ID: 19728850
[TBL] [Abstract][Full Text] [Related]
9. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.
Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schoen RE; Hashash JG; Schwartz M; Swoger J; Baidoo L; Barrie A; Dunn MA; Binion DG
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1760-6. PubMed ID: 25862987
[TBL] [Abstract][Full Text] [Related]
10. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-
Shu W; Pang Z; Xu C; Lin J; Li G; Wu W; Sun S; Li J; Li X; Liu Z
Mediators Inflamm; 2019; 2019():4038619. PubMed ID: 31814801
[TBL] [Abstract][Full Text] [Related]
12. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.
Antunes CV; Hallack Neto AE; Nascimento CR; Chebli LA; Moutinho IL; Pinheiro Bdo V; Reboredo MM; Malaguti C; Castro AC; Chebli JM
Biomed Res Int; 2015; 2015():728925. PubMed ID: 25705682
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: are there different trends in ileitis versus colitis?
Charron M
J Nucl Med; 2003 Oct; 44(10):1586-91. PubMed ID: 14530471
[TBL] [Abstract][Full Text] [Related]
14. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
[TBL] [Abstract][Full Text] [Related]
15. Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.
Bodelier AG; Pierik MJ; van den Heuvel T; Bovee-Oudenhoven IM; de Boer E; Hameeteman W; Masclee AA; Jonkers D
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):902-9. PubMed ID: 24915490
[TBL] [Abstract][Full Text] [Related]
16. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
17. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.
Abautret-Daly Á; Dempsey E; Riestra S; de Francisco-García R; Parra-Blanco A; Rodrigo L; Medina C; Connor TJ; Harkin A
Int J Psychiatry Clin Pract; 2017 Sep; 21(3):221-230. PubMed ID: 28353360
[TBL] [Abstract][Full Text] [Related]
18. Serum prohepcidin levels in chronic inflammatory bowel diseases.
Nagy J; Lakner L; Poór VS; Pandur E; Mózsik G; Miseta A; Sipos K
J Crohns Colitis; 2010 Dec; 4(6):649-53. PubMed ID: 21122575
[TBL] [Abstract][Full Text] [Related]
19. Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease.
Legeret C; Mählmann L; Gerber M; Kalak N; Köhler H; Holsboer-Trachsler E; Brand S; Furlano R
BMC Pediatr; 2019 Aug; 19(1):297. PubMed ID: 31455308
[TBL] [Abstract][Full Text] [Related]
20. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.
Street ME; de'Angelis G; Camacho-Hübner C; Giovannelli G; Ziveri MA; Bacchini PL; Bernasconi S; Sansebastiano G; Savage MO
Horm Res; 2004; 61(4):159-64. PubMed ID: 14691340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
